Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Myocilin Variants on IOP and BP with Cosopt
NCT00906087Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Aug 2009
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dorzolamide in Open-angle glaucoma (OAG), sponsored by University of Michigan. Primary endpoints: Intraocular Pressure in Sitting and Supine Positions at 10 weeks and Blood Pressure in Sitting to Supine Positions at 10 weeks. Started Aug 2009; status: completed.
02
Drugs
dorzolamide
03
Conditions
Open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT00906087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00906087.